{"organizations": [], "uuid": "dfe58ebf802c0d584e18e8038a0a7162f2cd7005", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "https://si.wsj.net/public/resources/images/BN-XE862_3azFC_TOP_20180126175241.jpg", "site_section": "https://www.wsj.com/news/business", "section_title": "Business &amp; Finance News - Wall Street Journal", "url": "https://www.wsj.com/articles/abbvie-gives-more-juice-to-drug-rally-1517065200", "country": "US", "domain_rank": 387, "title": "AbbVie Gives More Juice to Drug Rally", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.004, "site_type": "news", "published": "2018-01-27T18:00:00.000+02:00", "replies_count": 0, "uuid": "dfe58ebf802c0d584e18e8038a0a7162f2cd7005"}, "author": "Charley Grant", "url": "https://www.wsj.com/articles/abbvie-gives-more-juice-to-drug-rally-1517065200", "ord_in_thread": 0, "title": "AbbVie Gives More Juice to Drug Rally", "locations": [], "entities": {"persons": [], "locations": [{"name": "humira", "sentiment": "none"}], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "The world’s hottest big drug company had good news for more than just its own shareholders. Investors in companies focused on hepatitis C treatments also had new reasons to celebrate.\nAbbVie shares rose 14% to record highs after reporting strong fourth-quarter results on Friday, and they have doubled over the past year. There was much for investors to admire. Fourth-quarter revenue from Humira, the world’s best-selling drug, grew by 14% from a year ago to $4.9 billion, boosted by higher volume and price increases. And AbbVie... To Read the Full Story Subscribe Sign In", "external_links": [], "published": "2018-01-27T18:00:00.000+02:00", "crawled": "2018-01-27T21:27:35.001+02:00", "highlightTitle": ""}